1. Home
  2. FMS vs AFRM Comparison

FMS vs AFRM Comparison

Compare FMS & AFRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fresenius Medical Care AG

FMS

Fresenius Medical Care AG

HOLD

Current Price

$22.61

Market Cap

12.5B

Sector

Health Care

ML Signal

HOLD

Logo Affirm Holdings Inc.

AFRM

Affirm Holdings Inc.

HOLD

Current Price

$64.37

Market Cap

14.3B

ML Signal

HOLD

Company Overview

Basic Information
Metric
FMS
AFRM
Founded
1996
2012
Country
Germany
United States
Employees
109698
N/A
Industry
Misc Health and Biotechnology Services
Business Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
12.5B
14.3B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
FMS
AFRM
Price
$22.61
$64.37
Analyst Decision
Sell
Buy
Analyst Count
2
25
Target Price
$30.00
$84.52
AVG Volume (30 Days)
456.5K
4.6M
Earning Date
05-05-2026
05-07-2026
Dividend Yield
2.57%
N/A
EPS Growth
N/A
108.98
EPS
N/A
0.60
Revenue
N/A
$3,224,412,000.00
Revenue This Year
N/A
$30.78
Revenue Next Year
$3.83
$23.95
P/E Ratio
$15.62
$105.98
Revenue Growth
N/A
38.80
52 Week Low
$20.96
$42.10
52 Week High
$30.46
$100.00

Technical Indicators

Market Signals
Indicator
FMS
AFRM
Relative Strength Index (RSI) 47.00 63.91
Support Level $22.50 $62.60
Resistance Level $24.02 $79.27
Average True Range (ATR) 0.36 3.18
MACD -0.07 0.35
Stochastic Oscillator 31.06 77.32

Price Performance

Historical Comparison
FMS
AFRM

About FMS Fresenius Medical Care AG

Fresenius Medical Care is the largest dialysis company in the world, treating nearly 300,000 patients from about 3,600 clinics worldwide as of December 2025. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourths of sales, while the balance is generated from medical technology products that enable dialysis treatments.

About AFRM Affirm Holdings Inc.

Founded in 2012, Affirm is a market leader in the buy-now, pay-later space with around $36 billion in transaction volume in fiscal 2025. Affirm offers both zero-interest financing, which is merchant subsidized, and interest-bearing loans, which function as personal loans that are approved on a per-transaction basis. Over 70% of Affirm's transaction volume comes from its interest-bearing loans, which also comprise the majority of its revenue. Affirm operates in the United States, which accounted for more than 95% of its revenue in 2025, but the firm has also expanded to Canada and the United Kingdom.

Share on Social Networks: